Literature DB >> 12682643

G-CSF for imatinib-induced neutropenia.

D Heim, M Ebnöther, S Meyer-Monard, D Tsakiris, M Linn, A Tichelli, A Gratwohl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12682643     DOI： 10.1038/sj.leu.2402869

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

1.  Berbamine overcomes imatinib-induced neutropenia and permits cytogenetic responses in Chinese patients with chronic-phase chronic myeloid leukemia.

Authors:  Yanmin Zhao; Yamin Tan; Gongqiang Wu; Lizhen Liu; Yingjia Wang; Yi Luo; Jimin Shi; He Huang
Journal:  Int J Hematol       Date:  2011-07-05       Impact factor: 2.490

2.  Dynamics and management of cytopenias associated with dasatinib therapy in patients with chronic myeloid leukemia in chronic phase after imatinib failure.

Authors:  Alfonso Quintás-Cardama; Fabio Pires De Souza Santos; Hagop Kantarjian; Susan O'Brien; Stefan Faderl; Ahmed Awais; Gautam Borthakur; Jorge Cortes
Journal:  Cancer       Date:  2009-09-01       Impact factor: 6.860

3.  Imatinib plus Granulocyte Colony-Stimulating Factor in Chronic Myeloid Leukemia Patients Who Have Achieved Partial or Complete Cytogenetic Response while on Imatinib.

Authors:  Baijun Fang; Ling Mai; Ning Li; Yongping Song; Robert Chunhua Zhao
Journal:  Case Rep Oncol       Date:  2011-04-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.